M. KEKLİK Et Al. , "Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma," TRANSFUSION AND APHERESIS SCIENCE , vol.59, no.5, 2020
KEKLİK, M. Et Al. 2020. Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma. TRANSFUSION AND APHERESIS SCIENCE , vol.59, no.5 .
KEKLİK, M., Karakus, E., KAYNAR, L., Akyol, G., Guven, Z. T., Celik, S., ... Baydar, M.(2020). Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma. TRANSFUSION AND APHERESIS SCIENCE , vol.59, no.5.
KEKLİK, MUZAFFER Et Al. "Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma," TRANSFUSION AND APHERESIS SCIENCE , vol.59, no.5, 2020
KEKLİK, MUZAFFER Et Al. "Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma." TRANSFUSION AND APHERESIS SCIENCE , vol.59, no.5, 2020
KEKLİK, M. Et Al. (2020) . "Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma." TRANSFUSION AND APHERESIS SCIENCE , vol.59, no.5.
@article{article, author={MUZAFFER KEKLİK Et Al. }, title={Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma}, journal={TRANSFUSION AND APHERESIS SCIENCE}, year=2020}